查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612968

西拉普利市場：按配方、形式、應用、分銷管道分類 - 2025-2030 年全球預測

Cilazapril Market by Formulation (Cilazapril Hydrochloride, Cilazapril Monohydrate), Form (Capsules, Tablets), Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年西拉普利市值為2.4002億美元，預計2024年將達到2.5157億美元，複合年成長率為5.07%，預計到2030年將達到3.3938億美元。

西拉普利是血管收縮素轉化酵素(ACE) 抑制劑，主要用於治療高血壓和心臟衰竭。隨著全世界心血管疾病的增加，對西拉普利等有效治療方法的需求不斷增加。其用途包括控制高血壓、降低中風和心肌梗塞的風險、協助治療心臟衰竭，進而提高患者的存活率和生活品質。最終用途包括醫院、診所和居家醫療場所，醫生單獨制定它或與其他治療方法結合使用。由於越來越多的老年人更容易患心血管疾病，對西拉普利等有效抗高血壓藥物的組合和需求不斷增加，影響了市場成長。由於醫療保健和意識的改善，新興市場提供了巨大的商機。藥物組合和新的給藥方法等創新可以提高療效和患者依從性，從而提供利潤豐厚的成長途徑。然而，ACE 抑制劑與咳嗽和高血鉀等副作用有關，這可能會限制其使用。此外，來自血管收縮素II 受體阻斷劑 (ARB) 等替代藥物類別的競爭也是一個挑戰。學名藥的流行也影響品牌藥的市場佔有率和盈利。為了緩解這些挑戰，公司可以投資研究新適應症和改進的輸送系統。此外，透過進入亞太和拉丁美洲不斷成長的市場，我們將能夠開拓並推動心血管疾病日益流行但診斷不足的市場的成長。在這些地區實施教育舉措以提高診斷和治療依從性可以擴大基本客群。總體而言，該市場競爭適中，具有巨大的創新和成長空間，特別是透過飽和度較低的地理細分市場以及治療應用和輸送機制的多樣化。

主要市場統計
基準年[2023] 24002萬美元
預計年份 [2024] 25157萬美元
預測年份 [2030] 33938萬美元
複合年成長率（%） 5.07%

市場動態：揭示快速發展的西拉普利市場的關鍵市場洞察

供需的動態交互作用正在改變西拉普利市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 高血壓和心臟病的盛行率增加
    • 各國老年人口數量增加
  • 市場限制因素
    • 與西拉普利相關的產品召回和副作用
  • 市場機會
    • 加強醫療資金籌措和基礎建設
    • 聯合治療以增強藥物療效
  • 市場問題
    • 替代治療的可用性

波特的五力：駕馭西拉普利市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解西拉普利市場的外部影響

外部宏觀環境因素在塑造西拉普利市場的業績動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解西拉普利市場的競爭格局

對西拉普利市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：西拉普利市場供應商績效評估

FPNV定位矩陣是評估西拉普利市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製西拉普利市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，西拉普利市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 高血壓和心臟病的發生率增加
      • 各國人口老化進展
    • 抑制因素
      • 與西拉普利相關的產品召回和副作用
    • 機會
      • 增加醫療保健方面的資金和改善基礎設施
      • 聯合治療以增強藥物療效
    • 任務
      • 替代治療方法的可用性
  • 市場區隔分析
    • 配方：經常使用鹽酸西拉普利以增加藥物溶解度和穩定性
    • 用途：擴大西拉普利藥物的服用量，以降低高血壓、預防心臟病和腎臟問題
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 西拉普利市場：依配方分類

  • 介紹
  • 鹽酸西拉普利
  • 西拉普利一水化合物

第7章 西拉普利市場：依形式

  • 介紹
  • 膠囊
  • 錠劑

第8章西拉普利市場：依應用分類

  • 介紹
  • 心臟衰竭管理
  • 高血壓管理

第9章西拉普利市場：按分銷管道

  • 介紹
  • 醫院藥房
  • 線下零售藥局
  • 網路藥房

第10章 西拉普利美洲市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太西拉普利市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 西拉普利歐洲、中東和非洲市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Lupin 獲得美國FDA核准西拉普利非專利
  • 戰略分析和建議

公司名單

  • Adooq Bioscience LLC
  • ANGLE BIO PHARMA
  • ApexBio Technology
  • Biorbyt Ltd.
  • Biosynth Ltd.
  • Cayman Chemical
  • Chemicea Limited
  • Enomark
  • He Ako Hiringa
  • Hetero Labs Limited
  • LGM Pharma
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • MIMS Pte Ltd.
  • Santa Cruz BIoTechnology, Inc.
Product Code: MRR-7949F05838FE

The Cilazapril Market was valued at USD 240.02 million in 2023, expected to reach USD 251.57 million in 2024, and is projected to grow at a CAGR of 5.07%, to USD 339.38 million by 2030.

Cilazapril is an angiotensin-converting enzyme (ACE) inhibitor primarily used for managing hypertension and heart failure. As the presence of cardiovascular diseases rises globally, the necessity for effective treatments like Cilazapril grows. Its application spans controlling high blood pressure, reducing the risk of strokes and myocardial infarction, and aiding in the management of heart failure, thereby improving patient survival and quality of life. End-use scope includes hospitals, clinics, and home care settings, wherein physicians prescribe it singularly or in combination with other therapeutic regimens. Market growth is influenced by the rising geriatric population susceptible to cardiovascular ailments, leading to increased prescription and demand for effective antihypertensive medications like Cilazapril. Emerging markets are offering vast opportunities due to increasing healthcare access and awareness. Innovations such as combination drugs or new delivery methodologies could enhance efficacy or patient compliance, providing lucrative growth avenues. However, the market faces limitations from side effects associated with ACE inhibitors, like cough and hyperkalemia, which may restrain usage. Furthermore, competition from alternative drug classes like angiotensin II receptor blockers (ARBs) presents challenges. Generic drug penetration also impacts market share and profitability for branded versions. To mitigate these challenges, firms can invest in research for Cilazapril's possible new indications or improved delivery systems. Additionally, tapping into growing markets in Asia-Pacific and Latin America, where cardiovascular diseases are increasingly prevalent but underdiagnosed, could drive growth. Conducting educational initiatives to increase diagnosis and treatment compliance in those regions might expand the customer base. Overall, the market is moderately competitive with significant room for innovation and growth, particularly in less saturated geographic sectors and through diversification of treatment applications and delivery mechanisms.

KEY MARKET STATISTICS
Base Year [2023] USD 240.02 million
Estimated Year [2024] USD 251.57 million
Forecast Year [2030] USD 339.38 million
CAGR (%) 5.07%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cilazapril Market

The Cilazapril Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of hypertension and heart conditions
    • Growing geriatric population across countries
  • Market Restraints
    • Product recall and side effects associated with cilazapril
  • Market Opportunities
    • Enhanced funding and infrastructure improvements in healthcare
    • Combination therapies to enhance drug efficacy
  • Market Challenges
    • Availability of alternative treatments

Porter's Five Forces: A Strategic Tool for Navigating the Cilazapril Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cilazapril Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cilazapril Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cilazapril Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cilazapril Market

A detailed market share analysis in the Cilazapril Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cilazapril Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cilazapril Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cilazapril Market

A strategic analysis of the Cilazapril Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cilazapril Market, highlighting leading vendors and their innovative profiles. These include Adooq Bioscience LLC, ANGLE BIO PHARMA, ApexBio Technology, Biorbyt Ltd., Biosynth Ltd., Cayman Chemical, Chemicea Limited, Enomark, He Ako Hiringa, Hetero Labs Limited, LGM Pharma, Manus Aktteva Biopharma LLP, Merck KGaA, MIMS Pte Ltd., and Santa Cruz Biotechnology, Inc..

Market Segmentation & Coverage

This research report categorizes the Cilazapril Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Formulation, market is studied across Cilazapril Hydrochloride and Cilazapril Monohydrate.
  • Based on Form, market is studied across Capsules and Tablets.
  • Based on Application, market is studied across Heart Failure Management and Hypertension Management.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Offline Retail Pharmacies, and Online Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of hypertension and heart conditions
      • 5.1.1.2. Growing geriatric population across countries
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and side effects associated with cilazapril
    • 5.1.3. Opportunities
      • 5.1.3.1. Enhanced funding and infrastructure improvements in healthcare
      • 5.1.3.2. Combination therapies to enhance drug efficacy
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Extensive usage of cilazapril hydrochloride formulation to enhance medication's solubility and stability
    • 5.2.2. Application: Expanding consumption of cilazapril drugs to lower high blood pressure, prevent heart attacks, and kidney problems
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cilazapril Market, by Formulation

  • 6.1. Introduction
  • 6.2. Cilazapril Hydrochloride
  • 6.3. Cilazapril Monohydrate

7. Cilazapril Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Tablets

8. Cilazapril Market, by Application

  • 8.1. Introduction
  • 8.2. Heart Failure Management
  • 8.3. Hypertension Management

9. Cilazapril Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Offline Retail Pharmacies
  • 9.4. Online Pharmacies

10. Americas Cilazapril Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cilazapril Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cilazapril Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Lupin Secures USFDA Approval for Generic Cilazapril
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adooq Bioscience LLC
  • 2. ANGLE BIO PHARMA
  • 3. ApexBio Technology
  • 4. Biorbyt Ltd.
  • 5. Biosynth Ltd.
  • 6. Cayman Chemical
  • 7. Chemicea Limited
  • 8. Enomark
  • 9. He Ako Hiringa
  • 10. Hetero Labs Limited
  • 11. LGM Pharma
  • 12. Manus Aktteva Biopharma LLP
  • 13. Merck KGaA
  • 14. MIMS Pte Ltd.
  • 15. Santa Cruz Biotechnology, Inc.

LIST OF FIGURES

  • FIGURE 1. CILAZAPRIL MARKET RESEARCH PROCESS
  • FIGURE 2. CILAZAPRIL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CILAZAPRIL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CILAZAPRIL MARKET DYNAMICS
  • TABLE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL MONOHYDRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CILAZAPRIL MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CILAZAPRIL MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CILAZAPRIL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CILAZAPRIL MARKET SIZE, BY OFFLINE RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CILAZAPRIL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023